• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿激酶型纤溶酶原激活剂(u-PA)在卵巢良性、交界性及恶性肿瘤中的表达

u-PA expression in benign, borderline and malignant ovarian tumors.

作者信息

Kiziridou A D, Toliou T, Stefanou D, Agnantis N

机构信息

Department of Pathology, Theagenion Anticancer Institute of Thessaloniki, Greece.

出版信息

Anticancer Res. 2002 Mar-Apr;22(2A):985-90.

PMID:12014682
Abstract

The malignant potential of solid tumors is related to their ability to invade adjacent tissue and to metastasize. The plasminogen activation system is one of the critical factors in tumor progression since it is involved in tumor invasion and metastasis. This study was performed to examine the expression of u-PA in benign, borderline and malignant tumors of the ovary by immunohistochemical evaluation on formalin-fixed, paraffin-embedded specimens applying monoclonal antibody 3689 directed to the b-chain of u-PA. Normal epithelial cells of the ovary (n = 5) showed no staining of u-PA but some stromal cells were slightly stained. Invasive carcinomas (n = 16) and borderline tumors (n = 15) showed a moderate to strong diffuse cytoplasmic staining. Benign tumors (n = 20) showed a variety of staining. The observation of randomly positive u-PA stromal cells is noteworthy. The percentage of u-PA-positive tumors was higher in carcinomas than in other tumors. There was no correlation with other known risk factors of malignancy such as differentiation, stage or type of tumor. In conclusion there are noticeable differences in u-PA expression among ovarian tumors and u-PA increase in ovarian tumors can be attributed to an increased diffuse cytoplasmic content in the neoplastic epithelial cells.

摘要

实体瘤的恶性潜能与其侵袭邻近组织和发生转移的能力有关。纤溶酶原激活系统是肿瘤进展的关键因素之一,因为它参与肿瘤侵袭和转移。本研究通过应用针对尿激酶型纤溶酶原激活剂(u-PA)b链的单克隆抗体3689,对福尔马林固定、石蜡包埋标本进行免疫组织化学评估,以检测u-PA在卵巢良性、交界性和恶性肿瘤中的表达。卵巢正常上皮细胞(n = 5)未显示u-PA染色,但一些基质细胞有轻微染色。浸润性癌(n = 16)和交界性肿瘤(n = 15)显示中度至强的弥漫性细胞质染色。良性肿瘤(n = 20)显示出多种染色情况。值得注意的是观察到随机出现的u-PA阳性基质细胞。u-PA阳性肿瘤的百分比在癌中高于其他肿瘤。与其他已知的恶性风险因素如肿瘤分化、分期或类型无关。总之,卵巢肿瘤之间u-PA表达存在显著差异,卵巢肿瘤中u-PA的增加可归因于肿瘤上皮细胞中弥漫性细胞质含量的增加。

相似文献

1
u-PA expression in benign, borderline and malignant ovarian tumors.尿激酶型纤溶酶原激活剂(u-PA)在卵巢良性、交界性及恶性肿瘤中的表达
Anticancer Res. 2002 Mar-Apr;22(2A):985-90.
2
Human ovarian tumors express gamma-glutamyl transpeptidase.人类卵巢肿瘤表达γ-谷氨酰转肽酶。
Cancer Res. 1994 Jan 1;54(1):286-90.
3
Expression of cyclooxygenase-2 and inducible nitric oxide synthase in human ovarian tumors and tumor-associated macrophages.环氧化酶-2和诱导型一氧化氮合酶在人卵巢肿瘤及肿瘤相关巨噬细胞中的表达
Cancer Res. 2001 Oct 1;61(19):7305-9.
4
Differential expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 protein and mRNA in epithelial ovarian tumors.基质金属蛋白酶-9和金属蛋白酶组织抑制剂-1蛋白及mRNA在上皮性卵巢肿瘤中的差异表达
Gynecol Oncol. 2000 Jun;77(3):369-76. doi: 10.1006/gyno.2000.5806.
5
Proliferative activity and p53 over-expression of ovarian epithelial tumors.卵巢上皮性肿瘤的增殖活性及p53过表达
Gen Diagn Pathol. 1995 Oct;141(2):131-9.
6
Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors): a reevaluation of the concept of stromal microinvasion.低恶性潜能卵巢浆液性肿瘤(交界性肿瘤)的间质浸润模式:对间质微浸润概念的重新评估
Am J Surg Pathol. 2006 Oct;30(10):1209-21. doi: 10.1097/01.pas.0000213299.11649.fa.
7
KRAS and BRAF mutations in ovarian tumors: a comprehensive study of invasive carcinomas, borderline tumors and extraovarian implants.卵巢肿瘤中的KRAS和BRAF突变:对浸润性癌、交界性肿瘤和卵巢外种植体的综合研究
Gynecol Oncol. 2006 Dec;103(3):883-7. doi: 10.1016/j.ygyno.2006.05.029. Epub 2006 Jun 30.
8
Overexpression of H-Ryk in mouse fibroblasts confers transforming ability in vitro and in vivo: correlation with up-regulation in epithelial ovarian cancer.H-Ryk在小鼠成纤维细胞中的过表达赋予其体内外转化能力:与上皮性卵巢癌中的上调相关。
Cancer Res. 1999 May 15;59(10):2265-70.
9
B7-H4 overexpression in ovarian tumors.B7-H4在卵巢肿瘤中的过表达。
Gynecol Oncol. 2006 Jan;100(1):44-52. doi: 10.1016/j.ygyno.2005.08.060. Epub 2005 Oct 26.
10
[Expressions of Cx43 and Skp2 in epithelial ovarian tumor and their clinical significances].[Cx43和Skp2在上皮性卵巢肿瘤中的表达及其临床意义]
Ai Zheng. 2005 Jan;24(1):104-9.

引用本文的文献

1
Proteolysis is the most fundamental property of malignancy and its inhibition may be used therapeutically (Review).蛋白水解作用是恶性肿瘤最基本的特性,其抑制作用可能具有治疗用途(综述)。
Int J Mol Med. 2019 Jan;43(1):15-25. doi: 10.3892/ijmm.2018.3983. Epub 2018 Nov 7.